Found: 15
Select item for more details and to access through your institution.
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study.
- Published in:
- Life (2075-1729), 2023, v. 13, n. 1, p. 191, doi. 10.3390/life13010191
- By:
- Publication type:
- Article
Inhibition of Vascular Smooth Muscle and Cancer Cell Proliferation by New VEGFR Inhibitors and Their Immunomodulator Effect: Design, Synthesis, and Biological Evaluation.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2021, p. 1, doi. 10.1155/2021/8321400
- By:
- Publication type:
- Article
Design and In Silico and In Vitro Evaluations of a Novel Nicotinamide Derivative as a VEGFR-2 Inhibitor.
- Published in:
- Journal of Chemistry, 2024, v. 2024, p. 1, doi. 10.1155/2024/2176512
- By:
- Publication type:
- Article
A Theobromine Derivative with Anticancer Properties Targeting VEGFR‐2: Semisynthesis, in silico and in vitro Studies.
- Published in:
- ChemistryOpen, 2023, v. 12, n. 10, p. 1, doi. 10.1002/open.202300066
- By:
- Publication type:
- Article
New quinoxalin‐2(1H)‐one‐derived VEGFR‐2 inhibitors: Design, synthesis, in vitro anticancer evaluations, in silico ADMET, and docking studies.
- Published in:
- Archiv der Pharmazie, 2022, v. 355, n. 7, p. 1, doi. 10.1002/ardp.202200048
- By:
- Publication type:
- Article
(E)- N -(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer Studies.
- Published in:
- Molecules, 2022, v. 27, n. 22, p. 7719, doi. 10.3390/molecules27227719
- By:
- Publication type:
- Article
Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies.
- Published in:
- Molecules, 2022, v. 27, n. 19, p. 6203, doi. 10.3390/molecules27196203
- By:
- Publication type:
- Article
New Anticancer Theobromine Derivative Targeting EGFR WT and EGFR T790M : Design, Semi-Synthesis, In Silico, and In Vitro Anticancer Studies.
- Published in:
- Molecules, 2022, v. 27, n. 18, p. 5859, doi. 10.3390/molecules27185859
- By:
- Publication type:
- Article
Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects.
- Published in:
- Molecules, 2022, v. 27, n. 14, p. N.PAG, doi. 10.3390/molecules27144606
- By:
- Publication type:
- Article
Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2.
- Published in:
- Molecules, 2022, v. 27, n. 13, p. 4079, doi. 10.3390/molecules27134079
- By:
- Publication type:
- Article
A New Theobromine-Based EGFR WT and EGFR T790M Inhibitor and Apoptosis Inducer: Design, Semi-Synthesis, Docking, DFT, MD Simulations, and In Vitro Studies.
- Published in:
- Processes, 2022, v. 10, n. 11, p. 2290, doi. 10.3390/pr10112290
- By:
- Publication type:
- Article
The Assessment of Anticancer and VEGFR-2 Inhibitory Activities of a New 1 H -Indole Derivative: In Silico and In Vitro Approaches.
- Published in:
- Processes, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/pr10071391
- By:
- Publication type:
- Article
Computer-Assisted Drug Discovery of a Novel Theobromine Derivative as an EGFR Protein-Targeted Apoptosis Inducer.
- Published in:
- Evolutionary Bioinformatics, 2023, p. 1, doi. 10.1177/11769343231217916
- By:
- Publication type:
- Article
Computer-Assisted Drug Discovery of a Novel Theobromine Derivative as an EGFR Protein-Targeted Apoptosis Inducer.
- Published in:
- Evolutionary Bioinformatics, 2023, v. 19, p. 1, doi. 10.1177/11769343231217916
- By:
- Publication type:
- Article
Anticancer derivative of the natural alkaloid, theobromine, inhibiting EGFR protein: Computer-aided drug discovery approach.
- Published in:
- PLoS ONE, 2023, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0282586
- By:
- Publication type:
- Article